Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (7611)	5/1/1998 8:02:00 PM
From: AlienTech	Read Replies (1) \| Respond to of 23519

To: +Jenna (8859 ) From: +AlienTech Friday, May 1 1998 4:24PM ET Reply # of 8888 >>I was asked about vvus. I decided to research it. If I were a man I would NOT use MUSE<< You are mistaking treatment with an enhancer. Also you didnt mention the various side effects of viagra. Also the fact that it cannot be used with a variety of medications. Any drug which lowers blood pressure can become addictive very easily due to its "getting a high off it" and after a while the dosage needs to increase. Lowering the blood pressure is not the only side effect. So the answer of "If I were a man I would NOT use MUSE" is irrelevant. Its not a recreational drug designed to enhance performace but targeted at a very small audience with some real problems which is about 20% of the people with ed problems not the ones who think they do. People who have ED are mostly above 50, people with some types of prostate or spinal cord injuries, diabeties, people with heart problems and people who have nerve damage. Monday should be telling, by now almost everyone who used to take MUSE have tried Viagra, so the refills should drop by more than half and new scripts should also drop drastically to less than half. Any other scenerio would be that there's a lot of people who can not take a pill. MCHM, HVSF, ZONA etc have the same drug but in cream or pill form but less effective that way. Somcething that is even more effective is caverjet who has 25% of VVUS market share. I would not think this would change. Dum de dum dum... And for next week we have VVUS in the front lines ready to spike some shorts..